• Report SKU:SKU: HVR3409
  • Description
  • Table of Contents
  • Request Sample

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next eight years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments. This research report analyzes the global markets with in-depth insights. The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K., Spain and ROE), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC), South America (Argentina, Brazil, Venezuela, Chile, and Peru) and Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, and Rest of MEA). Annual estimations and forecasts are provided from the year 2016 to 2027 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities. This report provides: ●  Market Sizing estimations and forecasts across the given market segments ●  Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, ) ●  Strategic recommendations in key business segments based on the market estimations ●  Regional and country level market analysis ●  Competitive landscaping of major market players ●  Company profiling covering the financials, recent activities and the future strategies

1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research Sources
1.4.2 Primary Research Sources
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Respiratory Disease Testing Market by Product
5.1 Introduction
5.2 Imaging Tests
5.3 Respiratory Measurement Devices
5.3.1 Capnographs
5.3.2 Pulse oximetry systems
5.3.3 Spirometers
5.3.4 Peak Flowmeters
5.4 Blood Gas Tests
5.5 Lung Volume Tests
5.6 OSA Diagnostic Test
5.7 Pulmonary Function Test

6 Respiratory Disease Testing Market by IVD Test
6.1 Introduction
6.2 POC Test
6.3 Molecular Diagnostic Test

7 Respiratory Disease Testing Market by End User
7.1 Introduction
7.2 Clinical Laboratories
7.3 Hospitals
7.4 Physician Clinics
7.5 Commercial/Private Labs
7.6 Public Health Labs

8 Geographical Segmentation
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 South America
8.4.1 Argentina
8.4.2 Brazil
8.4.3 Venezuela
8.4.4 Chile
8.4.5 Peru
8.5 Middle East & Africa
8.5.1 UAE
8.5.2 Saudi Arabia
8.5.3 Qatar
8.5.4 Iran
8.5.5 South Africa
8.5.6 Rest of Middle East & Africa

9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiles
10.1 Medtronic
10.2 Koninklijke Philips N.V.(Respironics)
10.3 GE Healthcare
10.4 Fischer & Paykel
10.5 Becton Dickinson & Company
10.6 CAREstream Medical Ltd
10.7 ResMed Company
10.8 MGC Diagnostics Corporation and Subsidiaries
10.9 Nihon Kohden Corporation
10.10 CareFusion Corporation
10.11 ndd Medical Technologies Inc (EasyOne Pro LAB)
10.12 SDI Diagnostics
10.13 COSMED
10.14 Smiths Medical
10.15 Perkin Elmer Inc
10.16 Bio-Rad
10.17 Abbott
10.18 Affymetrix

11 Appendix

12 Disclaimer

List of Tables
Table 1 Global Respiratory Disease Testing Market Analysis, by Region, (2017-2027) ($MN)
Table 2 Global Respiratory Disease Testing Market Analysis, by Product, (2017-2027) ($MN)
Table 3 Global Respiratory Disease Testing Market Analysis, by Imaging Tests, (2017-2027) ($MN)
Table 4 Global Respiratory Disease Testing Market Analysis, by Respiratory Measurement Devices, (2017-2027) ($MN)
Table 5 Global Respiratory Disease Testing Market Analysis, by Capnographs, (2017-2027) ($MN)
Table 6 Global Respiratory Disease Testing Market Analysis, by Pulse oximetry systems, (2017-2027) ($MN)
Table 7 Global Respiratory Disease Testing Market Analysis, by Spirometers, (2017-2027) ($MN)
Table 8 Global Respiratory Disease Testing Market Analysis, by Peak Flowmeters, (2017-2027) ($MN)
Table 9 Global Respiratory Disease Testing Market Analysis, by Blood Gas Tests, (2017-2027) ($MN)
Table 10 Global Respiratory Disease Testing Market Analysis, by Lung Volume Tests, (2017-2027) ($MN)
Table 11 Global Respiratory Disease Testing Market Analysis, by OSA Diagnostic Test, (2017-2027) ($MN)
Table 12 Global Respiratory Disease Testing Market Analysis, by Pulmonary Function Test, (2017-2027) ($MN)
Table 13 Global Respiratory Disease Testing Market Analysis, by IVD Test, (2017-2027) ($MN)
Table 14 Global Respiratory Disease Testing Market Analysis, by POC Test, (2017-2027) ($MN)
Table 15 Global Respiratory Disease Testing Market Analysis, by Molecular Diagnostic Test, (2017-2027) ($MN)
Table 16 Global Respiratory Disease Testing Market Analysis, by End User, (2017-2027) ($MN)
Table 17 Global Respiratory Disease Testing Market Analysis, by Clinical Laboratories, (2017-2027) ($MN)
Table 18 Global Respiratory Disease Testing Market Analysis, by Hospitals, (2017-2027) ($MN)
Table 19 Global Respiratory Disease Testing Market Analysis, by Physician Clinics, (2017-2027) ($MN)
Table 20 Global Respiratory Disease Testing Market Analysis, by Commercial/Private Labs, (2017-2027) ($MN)
Table 21 Global Respiratory Disease Testing Market Analysis, by Public Health Labs, (2017-2027) ($MN)
Table 22 North America Respiratory Disease Testing Market Analysis, by Country, (2017-2027) ($MN)
Table 23 North America Respiratory Disease Testing Market Analysis, by Product, (2017-2027) ($MN)
Table 24 North America Respiratory Disease Testing Market Analysis, by Imaging Tests, (2017-2027) ($MN)
Table 25 North America Respiratory Disease Testing Market Analysis, by Respiratory Measurement Devices, (2017-2027) ($MN)
Table 26 North America Respiratory Disease Testing Market Analysis, by Capnographs, (2017-2027) ($MN)
Table 27 North America Respiratory Disease Testing Market Analysis, by Pulse oximetry systems, (2017-2027) ($MN)
Table 28 North America Respiratory Disease Testing Market Analysis, by Spirometers, (2017-2027) ($MN)
Table 29 North America Respiratory Disease Testing Market Analysis, by Peak Flowmeters, (2017-2027) ($MN)
Table 30 North America Respiratory Disease Testing Market Analysis, by Blood Gas Tests, (2017-2027) ($MN)
Table 31 North America Respiratory Disease Testing Market Analysis, by Lung Volume Tests, (2017-2027) ($MN)
Table 32 North America Respiratory Disease Testing Market Analysis, by OSA Diagnostic Test, (2017-2027) ($MN)
Table 33 North America Respiratory Disease Testing Market Analysis, by Pulmonary Function Test, (2017-2027) ($MN)
Table 34 North America Respiratory Disease Testing Market Analysis, by IVD Test, (2017-2027) ($MN)
Table 35 North America Respiratory Disease Testing Market Analysis, by POC Test, (2017-2027) ($MN)
Table 36 North America Respiratory Disease Testing Market Analysis, by Molecular Diagnostic Test, (2017-2027) ($MN)
Table 37 North America Respiratory Disease Testing Market Analysis, by End User, (2017-2027) ($MN)
Table 38 North America Respiratory Disease Testing Market Analysis, by Clinical Laboratories, (2017-2027) ($MN)
Table 39 North America Respiratory Disease Testing Market Analysis, by Hospitals, (2017-2027) ($MN)
Table 40 North America Respiratory Disease Testing Market Analysis, by Physician Clinics, (2017-2027) ($MN)
Table 41 North America Respiratory Disease Testing Market Analysis, by Commercial/Private Labs, (2017-2027) ($MN)
Table 42 North America Respiratory Disease Testing Market Analysis, by Public Health Labs, (2017-2027) ($MN)
Table 43 Europe Respiratory Disease Testing Market Analysis, by Country, (2017-2027) ($MN)
Table 44 Europe Respiratory Disease Testing Market Analysis, by Product, (2017-2027) ($MN)
Table 45 Europe Respiratory Disease Testing Market Analysis, by Imaging Tests, (2017-2027) ($MN)
Table 46 Europe Respiratory Disease Testing Market Analysis, by Respiratory Measurement Devices, (2017-2027) ($MN)
Table 47 Europe Respiratory Disease Testing Market Analysis, by Capnographs, (2017-2027) ($MN)
Table 48 Europe Respiratory Disease Testing Market Analysis, by Pulse oximetry systems, (2017-2027) ($MN)
Table 49 Europe Respiratory Disease Testing Market Analysis, by Spirometers, (2017-2027) ($MN)
Table 50 Europe Respiratory Disease Testing Market Analysis, by Peak Flowmeters, (2017-2027) ($MN)
Table 51 Europe Respiratory Disease Testing Market Analysis, by Blood Gas Tests, (2017-2027) ($MN)
Table 52 Europe Respiratory Disease Testing Market Analysis, by Lung Volume Tests, (2017-2027) ($MN)
Table 53 Europe Respiratory Disease Testing Market Analysis, by OSA Diagnostic Test, (2017-2027) ($MN)
Table 54 Europe Respiratory Disease Testing Market Analysis, by Pulmonary Function Test, (2017-2027) ($MN)
Table 55 Europe Respiratory Disease Testing Market Analysis, by IVD Test, (2017-2027) ($MN)
Table 56 Europe Respiratory Disease Testing Market Analysis, by POC Test, (2017-2027) ($MN)
Table 57 Europe Respiratory Disease Testing Market Analysis, by Molecular Diagnostic Test, (2017-2027) ($MN)
Table 58 Europe Respiratory Disease Testing Market Analysis, by End User, (2017-2027) ($MN)
Table 59 Europe Respiratory Disease Testing Market Analysis, by Clinical Laboratories, (2017-2027) ($MN)
Table 60 Europe Respiratory Disease Testing Market Analysis, by Hospitals, (2017-2027) ($MN)
Table 61 Europe Respiratory Disease Testing Market Analysis, by Physician Clinics, (2017-2027) ($MN)
Table 62 Europe Respiratory Disease Testing Market Analysis, by Commercial/Private Labs, (2017-2027) ($MN)
Table 63 Europe Respiratory Disease Testing Market Analysis, by Public Health Labs, (2017-2027) ($MN)
Table 64 Asia Pacific Respiratory Disease Testing Market Analysis, by Country, (2017-2027) ($MN)
Table 65 Asia Pacific Respiratory Disease Testing Market Analysis, by Product, (2017-2027) ($MN)
Table 66 Asia Pacific Respiratory Disease Testing Market Analysis, by Imaging Tests, (2017-2027) ($MN)
Table 67 Asia Pacific Respiratory Disease Testing Market Analysis, by Respiratory Measurement Devices, (2017-2027) ($MN)
Table 68 Asia Pacific Respiratory Disease Testing Market Analysis, by Capnographs, (2017-2027) ($MN)
Table 69 Asia Pacific Respiratory Disease Testing Market Analysis, by Pulse oximetry systems, (2017-2027) ($MN)
Table 70 Asia Pacific Respiratory Disease Testing Market Analysis, by Spirometers, (2017-2027) ($MN)
Table 71 Asia Pacific Respiratory Disease Testing Market Analysis, by Peak Flowmeters, (2017-2027) ($MN)
Table 72 Asia Pacific Respiratory Disease Testing Market Analysis, by Blood Gas Tests, (2017-2027) ($MN)
Table 73 Asia Pacific Respiratory Disease Testing Market Analysis, by Lung Volume Tests, (2017-2027) ($MN)
Table 74 Asia Pacific Respiratory Disease Testing Market Analysis, by OSA Diagnostic Test, (2017-2027) ($MN)
Table 75 Asia Pacific Respiratory Disease Testing Market Analysis, by Pulmonary Function Test, (2017-2027) ($MN)
Table 76 Asia Pacific Respiratory Disease Testing Market Analysis, by IVD Test, (2017-2027) ($MN)
Table 77 Asia Pacific Respiratory Disease Testing Market Analysis, by POC Test, (2017-2027) ($MN)
Table 78 Asia Pacific Respiratory Disease Testing Market Analysis, by Molecular Diagnostic Test, (2017-2027) ($MN)
Table 79 Asia Pacific Respiratory Disease Testing Market Analysis, by End User, (2017-2027) ($MN)
Table 80 Asia Pacific Respiratory Disease Testing Market Analysis, by Clinical Laboratories, (2017-2027) ($MN)
Table 81 Asia Pacific Respiratory Disease Testing Market Analysis, by Hospitals, (2017-2027) ($MN)
Table 82 Asia Pacific Respiratory Disease Testing Market Analysis, by Physician Clinics, (2017-2027) ($MN)
Table 83 Asia Pacific Respiratory Disease Testing Market Analysis, by Commercial/Private Labs, (2017-2027) ($MN)
Table 84 Asia Pacific Respiratory Disease Testing Market Analysis, by Public Health Labs, (2017-2027) ($MN)
Table 85 South America Respiratory Disease Testing Market Analysis, by Country, (2017-2027) ($MN)
Table 86 South America Respiratory Disease Testing Market Analysis, by Product, (2017-2027) ($MN)
Table 87 South America Respiratory Disease Testing Market Analysis, by Imaging Tests, (2017-2027) ($MN)
Table 88 South America Respiratory Disease Testing Market Analysis, by Respiratory Measurement Devices, (2017-2027) ($MN)
Table 89 South America Respiratory Disease Testing Market Analysis, by Capnographs, (2017-2027) ($MN)
Table 90 South America Respiratory Disease Testing Market Analysis, by Pulse oximetry systems, (2017-2027) ($MN)
Table 91 South America Respiratory Disease Testing Market Analysis, by Spirometers, (2017-2027) ($MN)
Table 92 South America Respiratory Disease Testing Market Analysis, by Peak Flowmeters, (2017-2027) ($MN)
Table 93 South America Respiratory Disease Testing Market Analysis, by Blood Gas Tests, (2017-2027) ($MN)
Table 94 South America Respiratory Disease Testing Market Analysis, by Lung Volume Tests, (2017-2027) ($MN)
Table 95 South America Respiratory Disease Testing Market Analysis, by OSA Diagnostic Test, (2017-2027) ($MN)
Table 96 South America Respiratory Disease Testing Market Analysis, by Pulmonary Function Test, (2017-2027) ($MN)
Table 97 South America Respiratory Disease Testing Market Analysis, by IVD Test, (2017-2027) ($MN)
Table 98 South America Respiratory Disease Testing Market Analysis, by POC Test, (2017-2027) ($MN)
Table 99 South America Respiratory Disease Testing Market Analysis, by Molecular Diagnostic Test, (2017-2027) ($MN)
Table 100 South America Respiratory Disease Testing Market Analysis, by End User, (2017-2027) ($MN)
Table 101 South America Respiratory Disease Testing Market Analysis, by Clinical Laboratories, (2017-2027) ($MN)
Table 102 South America Respiratory Disease Testing Market Analysis, by Hospitals, (2017-2027) ($MN)
Table 103 South America Respiratory Disease Testing Market Analysis, by Physician Clinics, (2017-2027) ($MN)
Table 104 South America Respiratory Disease Testing Market Analysis, by Commercial/Private Labs, (2017-2027) ($MN)
Table 105 South America Respiratory Disease Testing Market Analysis, by Public Health Labs, (2017-2027) ($MN)
Table 106 Middle East & Africa Respiratory Disease Testing Market Analysis, by Country, (2017-2027) ($MN)
Table 107 Middle East & Africa Respiratory Disease Testing Market Analysis, by Product, (2017-2027) ($MN)
Table 108 Middle East & Africa Respiratory Disease Testing Market Analysis, by Imaging Tests, (2017-2027) ($MN)
Table 109 Middle East & Africa Respiratory Disease Testing Market Analysis, by Respiratory Measurement Devices, (2017-2027) ($MN)
Table 110 Middle East & Africa Respiratory Disease Testing Market Analysis, by Capnographs, (2017-2027) ($MN)
Table 111 Middle East & Africa Respiratory Disease Testing Market Analysis, by Pulse oximetry systems, (2017-2027) ($MN)
Table 112 Middle East & Africa Respiratory Disease Testing Market Analysis, by Spirometers, (2017-2027) ($MN)
Table 113 Middle East & Africa Respiratory Disease Testing Market Analysis, by Peak Flowmeters, (2017-2027) ($MN)
Table 114 Middle East & Africa Respiratory Disease Testing Market Analysis, by Blood Gas Tests, (2017-2027) ($MN)
Table 115 Middle East & Africa Respiratory Disease Testing Market Analysis, by Lung Volume Tests, (2017-2027) ($MN)
Table 116 Middle East & Africa Respiratory Disease Testing Market Analysis, by OSA Diagnostic Test, (2017-2027) ($MN)
Table 117 Middle East & Africa Respiratory Disease Testing Market Analysis, by Pulmonary Function Test, (2017-2027) ($MN)
Table 118 Middle East & Africa Respiratory Disease Testing Market Analysis, by IVD Test, (2017-2027) ($MN)
Table 119 Middle East & Africa Respiratory Disease Testing Market Analysis, by POC Test, (2017-2027) ($MN)
Table 120 Middle East & Africa Respiratory Disease Testing Market Analysis, by Molecular Diagnostic Test, (2017-2027) ($MN)
Table 121 Middle East & Africa Respiratory Disease Testing Market Analysis, by End User, (2017-2027) ($MN)
Table 122 Middle East & Africa Respiratory Disease Testing Market Analysis, by Clinical Laboratories, (2017-2027) ($MN)
Table 123 Middle East & Africa Respiratory Disease Testing Market Analysis, by Hospitals, (2017-2027) ($MN)
Table 124 Middle East & Africa Respiratory Disease Testing Market Analysis, by Physician Clinics, (2017-2027) ($MN)
Table 125 Middle East & Africa Respiratory Disease Testing Market Analysis, by Commercial/Private Labs, (2017-2027) ($MN)
Table 126 Middle East & Africa Respiratory Disease Testing Market Analysis, by Public Health Labs, (2017-2027) ($MN)